| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |